Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trimedyne

This article was originally published in The Gray Sheet

Executive Summary

Begins sales of OmniPulse-MAX 80-watt holmium surgical laser following receipt of 510(k) clearance. The laser, which Trimedyne claims is "more powerful than any competitive holmium laser" on the market, "is able to ablate tissue faster than any other laser whose energy can be transmitted through flexible optical fibers." OmniPulse-MAX is intended for use in orthopedics, urology, endosinus surgery, and general surgery...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002413

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel